Retractable Technologies reports improved third-quarter 2025 earnings driven by better margins, investment gains and a shift toward domestic production.
RVP reports stronger second-quarter 2025 sales and narrows losses as domestic output offsets tariff headwinds.
Discover why Zacks rates Retractable Technologies as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore RVP's declining profitability amid rising costs, significant cash concerns and concentration risk.
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Thomas J. Shaw CEO | AMEX Exchange | 76129W105 CUSIP |
| US Country | 221 Employees | - Last Dividend | - Last Split | 4 May 2001 IPO Date |
Retractable Technologies, Inc. is a company focused on the innovation, production, and global distribution of safety syringes and other medical safety products. Founded in 1994, the company has established itself in the healthcare industry by offering solutions aimed at reducing the incidence of needlestick injuries among healthcare professionals. Retractable Technologies operates primarily out of Little Elm, Texas, serving the healthcare sectors across the United States, North and South America, and other international markets. The company has built a reputation for its commitment to safety and quality, distributing its products through a combination of general line and specialty distributors, international distribution partners, and a direct marketing network.